Citrullimycines, a process for their production and their use as pharmaceuticals

Details for Australian Patent Application No. 2002223566 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Kurz, Michael; Wink, Joachim; Hopmann, Cordula; Bronstrup, Mark

Agent Watermark

Pub. Number AU-B-2002223566

PCT Pub. Number WO02/28824

Priority 00121566 02.10.00 EP

Filing date 27 September 2001

Wipo publication date 15 April 2002

Acceptance publication date 22 December 2005

International Classifications

C07C 275/16 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/197 (2006.01)

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12P 13/00 (2006.01) Preparation of nitrogen-containing organic compounds

C12P 13/10 (2006.01) Preparation of nitrogen-containing organic compounds

C12R 1/465 (2006.01)

Event Publications

15 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

22 December 2005 Application Accepted

  Published as AU-B-2002223566

27 April 2006 Standard Patent Sealed

23 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002223567

2002223565